Practice Summary
Elizabeth joined Bozicevic, Field and Francis in 2008 as a technical advisor with expertise in the areas of immunology, neurobiology, stem cell biology, ophthalmology, molecular biology, genomics and drug discovery.

Liz received a Bachelor of Science degree with Honors from Williams College in 1990. She then joined Dr. Michael Young’s laboratory at the Rockefeller University in New York City as a research assistant, where she studied early neural and mesoderm development and circadian rhythms in Drosophila melanogaster. In 1993, she moved to M.I.T. where she began research for her Ph.D. with Dr. David Baltimore and Dr. Richard Hynes on the role of NF-kappaB in innate and adaptive immunity. Upon completion of her Ph.D. in 2000, Liz performed postdoctoral work with Dr. Susan McConnell at Stanford University, using genomic tools to investigate how neuronal cell fates become specified during the development of the mammalian brain. Most recently, Liz held a position as a senior scientist in the Ophthalmics department at Merck in West Point, PA, where she led a team that was responsible for designing screens to identify and optimize drug candidates for therapies to prevent the progression of age-related macular degeneration.

Liz has co-authored numerous articles on this work which have been published in highly respected peer-reviewed journals, including Cell, Neuron, Genes and Development, Journal of Experimental Medicine, Journal of Immunology, and Current Opinions in Neurobiology. Notable discoveries that she has published on include a role for Drosophila neurogenic genes in mesoderm differentiation, the requirement for the NF-kappa B family member RelA in the development of secondary lymphoid organs, and the role of the transcription factor Satb2 in regulating callosal projection neuron identity in the developing neocortex.